LRRK2DAT:CSFα-synuclein

Jing Wang1,2, Xixi Sun3, Yunfei Yin3

  • 1Division of Life Sciences and Medicine, Department of Urologic Oncology, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, 230031, China.

Journal of neurology
|September 13, 2025
PubMed
概括

帕金森病 (PD) 患者具有LRRK2突变和负的α-synuclein种子放大试验 (SAA) 显示较慢的多巴胺基损失. 脑液α-同核素SAA状态是LRRK2 PD诊断和预后的一个有用的生物标志物.